Literature DB >> 13609676

[Result of application of securinine in acute poliomyelitis].

G R BURAVTSEVA.   

Abstract

Entities:  

Keywords:  ALKALOIDS/therapeutic use; POLIOMYELITIS/therapy

Mesh：

Substances：

Year:  1958        PMID： 13609676

Source DB:  PubMed          Journal:  Farmakol Toksikol        ISSN： 0014-8318


× No keyword cloud information.
  5 in total

1.  Synthesis and Antiproliferative and Metabolic Evaluations of Novel Securinine Derivatives.

Authors:  Marc Perez; Tahar Ayad; Philippe Maillos; Valérie Poughon; Jacques Fahy; Virginie Ratovelomanana-Vidal
Journal:  ACS Med Chem Lett       Date:  2016-02-02       Impact factor: 4.345

2.  Securinine, a myeloid differentiation agent with therapeutic potential for AML.

Authors:  Kalpana Gupta; Amitabha Chakrabarti; Sonia Rana; Ritu Ramdeo; Bryan L Roth; Munna L Agarwal; William Tse; Mukesh K Agarwal; David N Wald
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

3.  Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease.

Authors:  Dmitri Leonoudakis; Anand Rane; Suzanne Angeli; Gordon J Lithgow; Julie K Andersen; Shankar J Chinta
Journal:  Mediators Inflamm       Date:  2017-04-04       Impact factor: 4.711

4.  Predicting therapeutic drugs for hepatocellular carcinoma based on tissue-specific pathways.

Authors:  Liang Yu; Meng Wang; Yang Yang; Fengdan Xu; Xu Zhang; Fei Xie; Lin Gao; Xiangzhi Li
Journal:  PLoS Comput Biol       Date:  2021-02-09       Impact factor: 4.475

Review 5.  Unique indolizidine alkaloid securinine is a promising scaffold for the development of neuroprotective and antitumor drugs.

Authors:  Sergey Klochkov; Margarita Neganova
Journal:  RSC Adv       Date:  2021-05-26       Impact factor: 4.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.